Benitec Biopharma (BNTC) Institutional Ownership $13.66 -0.27 (-1.94%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$13.68 +0.03 (+0.18%) As of 05/21/2025 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Benitec Biopharma (NASDAQ:BNTC)CurrentInstitutional OwnershipPercentage52.19%Number ofInstitutional Buyers(last 12 months)18TotalInstitutional Inflows(last 12 months)$158.21MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$7.49M Get BNTC Insider Trade Alerts Want to know when executives and insiders are buying or selling Benitec Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BNTC Institutional Buying and Selling by Quarter Benitec Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 Goldman Sachs Group Inc.45,883$597K0.0%N/A0.196% 5/16/2025 Infinitum Asset Management LLC1,125,000$14.64M4.7%+435.7%4.797% 5/16/2025 AWM Investment Company Inc.137,977$1.80M0.2%+35.2%0.588% 5/15/2025 MYDA Advisors LLC52,000$677K0.1%+4.0%0.222% 5/13/2025 Informed Momentum Co LLC39,330$512K0.1%N/A0.168% 4/7/2025 GAMMA Investing LLC77,605$1.01M0.0%+1,104.3%0.331% 2/26/2025 Infinitum Asset Management LLC210,000$2.65M1.4%N/A0.895% 2/18/2025 AWM Investment Company Inc.102,027$1.29M0.2%-83.7%0.439% 2/17/2025 Suvretta Capital Management LLC8,960,009$113.17M3.9%+1.5%38.587% 2/17/2025 Lion Point Capital LP62,000$783K4.1%+59.0%0.267% Get the Latest News and Ratings for BNTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Benitec Biopharma and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Janus Henderson Group PLC2,616,427$33.27M0.0%+198.5%11.268% 2/17/2025 Ameriprise Financial Inc.35,476$448K0.0%+138.4%0.153% 2/17/2025 683 Capital Management LLC35,817$452K0.0%N/A0.154% 2/14/2025 Schonfeld Strategic Advisors LLC260,417$3.29M0.0%-4.5%1.122% 2/14/2025 Northern Trust Corp38,200$482K0.0%+54.2%0.165% 2/14/2025 Adage Capital Partners GP L.L.C.1,972,524$24.91M0.0%+134.4%8.495% 2/14/2025 MYDA Advisors LLC50,000$632K0.2%N/A0.215% 2/12/2025 Geode Capital Management LLC197,096$2.49M0.0%+134.7%0.849% 2/12/2025 Franklin Resources Inc.2,939,287$37.12M0.0%+269.0%12.658% 2/11/2025 Simplify Asset Management Inc.76,337$964K0.0%-34.5%0.329% 11/16/2024 Geode Capital Management LLC83,987$772K0.0%+31.3%0.795% 11/15/2024 Janus Henderson Group PLC876,523$8.03M0.0%-2.7%8.300% 11/14/2024 Suvretta Capital Management LLC8,829,053$81.14M2.6%+422.0%83.640% 11/14/2024 Acuta Capital Partners LLC29,800$274K0.2%N/A0.282% 11/6/2024 Simplify Asset Management Inc.116,535$1.07M0.0%+127.5%1.104% 10/7/2024 GAMMA Investing LLC6,540$60K0.0%+20.3%0.070% 8/20/2024 Nantahala Capital Management LLC841,395$5.88M0.3%N/A8.982% 8/13/2024 Simplify Asset Management Inc.51,216$358K0.0%N/A0.547% 7/2/2024 GAMMA Investing LLC5,438$38K0.0%+53.0%0.058% 5/16/2024 Janus Henderson Group PLC244,491$1.27M0.0%+35.5%9.440% 11/15/2023 Adage Capital Partners GP L.L.C.189,188$572K0.0%N/A7.419% 11/15/2022Empery Asset Management LP796,837$296K1.8%N/A2.848% 11/15/2022 Cantor Fitzgerald L. P.133,805$50K0.0%N/A0.478% 11/14/2022 Armistice Capital LLC1,555,039$578K0.0%N/A6.025% 11/14/2022 Altium Capital Management LP658,796$245K0.1%N/A2.552% 11/9/2021BlackRock Inc.19,974$71K0.0%-16.4%0.244% 8/16/2021 State Street Corp21,000$89K0.0%N/A0.267% 8/13/2021 Renaissance Technologies LLC42,700$181K0.0%N/A0.544% 8/13/2021 Northern Trust Corp11,813$50K0.0%N/A0.150% 8/13/2021 Geode Capital Management LLC34,493$146K0.0%+20.8%0.439% Trump Exec Order 14179 is wealth “gift” to good Americans? (Ad)Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.If you missed out on a bitcoin fortune, this could be your second chance. A brief “wealth window” is8/13/2021 Vanguard Group Inc.74,773$318K0.0%+43.3%0.952% 8/11/2021 Bank of New York Mellon Corp14,932$63K0.0%-15.4%0.190% 7/31/2021 Private Wealth Advisors LLC15,043$64K0.0%N/A0.192% 5/21/2021 Citadel Advisors LLC23,253$120K0.0%N/A0.483% 5/19/2021 Virtu Financial LLC22,520$116K0.0%+17.8%0.467% 5/18/2021 Citadel Advisors LLC23,253$120K0.0%N/A0.483% 5/13/2021 Bank of New York Mellon Corp17,653$91K0.0%N/A0.366% 5/12/2021 Geode Capital Management LLC28,560$147K0.0%N/A0.593% (Data available from 1/1/2016 forward) BNTC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BNTC shares? During the previous two years, 19 institutional investors and hedge funds held shares of Benitec Biopharma. The most heavily invested institutionals were Suvretta Capital Management LLC ($113.17M), Franklin Resources Inc. ($37.12M), Janus Henderson Group PLC ($33.27M), Adage Capital Partners GP L.L.C. ($24.91M), Infinitum Asset Management LLC ($14.64M), Nantahala Capital Management LLC ($5.88M), and Schonfeld Strategic Advisors LLC ($3.29M).Learn more on BNTC's institutional investors. What percentage of Benitec Biopharma stock is owned by institutional investors? 52.19% of Benitec Biopharma stock is owned by institutional investors. Learn more on BNTC's institutional investor holdings. Which institutional investors have been buying Benitec Biopharma stock? Of the 18 institutional investors that purchased Benitec Biopharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Suvretta Capital Management LLC ($7.27M), Franklin Resources Inc. ($2.14M), Janus Henderson Group PLC ($1.80M), Adage Capital Partners GP L.L.C. ($1.32M), Infinitum Asset Management LLC ($1.13M), Nantahala Capital Management LLC ($841.40K), and Geode Capital Management LLC ($133.12K). How much institutional buying is happening at Benitec Biopharma? Institutional investors have bought a total of 15,121,675 shares in the last 24 months. This purchase volume represents approximately $159.12M in transactions. Which Benitec Biopharma major shareholders have been selling company stock? The following institutional investors have sold Benitec Biopharma stock in the last 24 months: AWM Investment Company Inc. ($522.97K), Simplify Asset Management Inc. ($40.20K), Janus Henderson Group PLC ($24.29K), and Schonfeld Strategic Advisors LLC ($12.40K). How much institutional selling is happening at Benitec Biopharma? Institutional investors have sold a total of 599,864 shares in the last 24 months. This volume of shares sold represents approximately $7.49M in transactions. Related Companies CALT Major Shareholders ETNB Major Shareholders OCUL Major Shareholders AMPH Major Shareholders AUPH Major Shareholders WVE Major Shareholders GYRE Major Shareholders PAHC Major Shareholders MLYS Major Shareholders COLL Major Shareholders This page (NASDAQ:BNTC) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Benitec Biopharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Benitec Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BNTC Stock Free BNTC Stock Alerts